{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:02:59Z","timestamp":1789848179807,"version":"4.0.1"},"reference-count":152,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["R01DK105155"],"award-info":[{"award-number":["R01DK105155"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["R01DK112812"],"award-info":[{"award-number":["R01DK112812"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["5T32DK007314"],"award-info":[{"award-number":["5T32DK007314"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopsych.2026.06.015","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:08:47Z","timestamp":1782400127000},"page":"840-849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["From Satiety to Substance Use: Neural Mechanisms of Glucagon-Like Peptide-1 Signaling in Appetite and Reward"],"prefix":"10.1016","volume":"100","author":[{"given":"Caitlin","family":"Baumer-Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan R.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.","family":"De Jonghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2026.06.015_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fnins.2013.00181","article-title":"The central GLP-1: Implications for food and drug reward","volume":"7","author":"Skibicka","year":"2013","journal-title":"Front Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr5051","article-title":"An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking","volume":"11","author":"Merkel","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.biopsych.2026.06.015_bib3","article-title":"The GLP-1R agonist semaglutide reduces motivated running and alters dopamine dynamics in the nucleus accumbens","author":"Foscue","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopsych.2026.06.015_bib4","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2026.06.015_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2500173","article-title":"Semaglutide in adults with type 1 diabetes and obesity","volume":"4","author":"Shah","year":"2025","journal-title":"NEJM Evid"},{"key":"10.1016\/j.biopsych.2026.06.015_bib6","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.cmet.2025.04.018","article-title":"Semaglutide effects on energy balance are mediated by Adcyap1+ neurons in the dorsal vagal complex","volume":"37","author":"Teixidor-Deulofeu","year":"2025","journal-title":"Cell Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/science.adt0773","article-title":"Hedonic eating is controlled by dopamine neurons that oppose GLP-1R satiety","volume":"387","author":"Zhu","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2026.06.015_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2025.07.001","article-title":"Semaglutide suppresses cocaine taking, seeking, and cocaine-evoked dopamine levels in the nucleus accumbens","volume":"98","author":"Aran\u00e4s","year":"2025","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00213-024-06637-2","article-title":"Effect of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide on alcohol consumption in alcohol-preferring male vervet monkeys","volume":"242","author":"Fink-Jensen","year":"2025","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.biopsych.2026.06.015_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapsychiatry.2024.4789","article-title":"Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial","volume":"82","author":"Hendershot","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.015_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13722-025-00618-2","article-title":"Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocol","volume":"20","author":"Freet","year":"2025","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.biopsych.2026.06.015_bib12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/M23-2718","article-title":"Association of semaglutide with tobacco use disorder in patients with type 2 diabetes: Target trial emulation using real-world data","volume":"177","author":"Wang","year":"2024","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.biopsych.2026.06.015_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12991-024-00527-9","article-title":"Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: A systematic review","volume":"23","author":"Lee","year":"2024","journal-title":"Ann Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.015_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2024.114565","article-title":"Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence","volume":"281","author":"Herman","year":"2024","journal-title":"Physiol Behav"},{"issue":"suppl 2","key":"10.1016\/j.biopsych.2026.06.015_bib15","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.2337\/db06-S020","article-title":"Glucagon-like peptide 1 secretion by the L-cell","volume":"55","author":"Lim","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.biopsych.2026.06.015_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2337\/db18-0729","article-title":"Preproglucagon neurons in the nucleus of the solitary tract are the main source of brain GLP-1, mediate stress-induced hypophagia, and limit unusually large intakes of food","volume":"68","author":"Holt","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.biopsych.2026.06.015_bib17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/cne.902710405","article-title":"Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: An immunocytochemical study","volume":"271","author":"Jin","year":"1988","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib18","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1523\/JNEUROSCI.2212-10.2011","article-title":"Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function","volume":"31","author":"Barrera","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib19","first-page":"199","article-title":"Satiation and stress-induced hypophagia: Examining the role of hindbrain neurons expressing prolactin-releasing peptide or glucagon-like peptide 1","volume":"6","author":"Maniscalco","year":"2012","journal-title":"Front Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib20","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3390\/ijms25021087","article-title":"Nutrient combinations sensed by L-cell receptors potentiate GLP-1 secretion","volume":"25","author":"Sodum","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108477","article-title":"Activation of PPG neurons following acute stressors differentially involves hindbrain serotonin in male rats","volume":"187","author":"Leon","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib22","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1375-25.2025","article-title":"GLP-1 receptor agonists and research to treat overeating and substance use disorders","volume":"45","author":"Guo","year":"2025","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib23","doi-asserted-by":"crossref","first-page":"10701","DOI":"10.1523\/JNEUROSCI.3464-14.2015","article-title":"Negative energy balance blocks neural and behavioral responses to acute stress by \u201csilencing\u201d central glucagon-like peptide 1 signaling in rats","volume":"35","author":"Maniscalco","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib24","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.2063-23.2024","article-title":"Populations of hindbrain glucagon-like peptide 1 (GLP1) neurons that innervate the hypothalamic PVH, thalamic PVT, or limbic forebrain BST have axon collaterals that reach all central regions innervated by GLP1 neurons","volume":"44","author":"Randolph","year":"2024","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh0980","article-title":"The locus coeruleus contributes to the anorectic, nausea, and autonomic physiological effects of glucagon-like peptide-1","volume":"9","author":"Fortin","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.biopsych.2026.06.015_bib26","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1523\/JNEUROSCI.2180-18.2019","article-title":"Chronic suppression of glucagon-like peptide-1 receptor (GLP1R) mRNA translation in the rat bed nucleus of the stria terminalis reduces anxiety-like behavior and stress-induced hypophagia, but prolongs stress-induced elevation of plasma corticosterone","volume":"39","author":"Zheng","year":"2019","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.nut.2009.07.008","article-title":"Exenatide and weight loss","volume":"26","author":"Bradley","year":"2010","journal-title":"Nutrition"},{"key":"10.1016\/j.biopsych.2026.06.015_bib28","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","article-title":"The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide","volume":"62","author":"Kanoski","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib29","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","article-title":"Effects of liraglutide in the treatment of obesity: A randomised, double-blind, placebo-controlled study","volume":"374","author":"Astrup","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2026.06.015_bib30","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4","volume":"152","author":"Kanoski","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopsych.2026.06.015_bib32","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib33","series-title":"StatPearls. Treasure Island, FL","article-title":"Compare and contrast the glucagon-like peptide-1 receptor agonists (GLP1RAs)","author":"Latif","year":"2025"},{"key":"10.1016\/j.biopsych.2026.06.015_bib34","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","article-title":"Distribution and characterisation of glucagon-like peptide-1 receptor expressing cells in the mouse brain","volume":"4","author":"Cork","year":"2015","journal-title":"Mol Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib35","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/db13-1440","article-title":"Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model","volume":"63","author":"Richards","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.biopsych.2026.06.015_bib36","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2022.06.002","article-title":"Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions","volume":"34","author":"Imbernon","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adu6764","article-title":"Hindbrain octadecaneuropeptide gliotransmission as a therapeutic target for energy balance control without nausea or emesis","volume":"17","author":"Geisler","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biopsych.2026.06.015_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/14728222.2026.2625931","article-title":"Therapeutic potential for glial-derived octadecaneuropeptide in the treatment of obesity","volume":"30","author":"Orativskyi","year":"2026","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.biopsych.2026.06.015_bib39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-024-07685-6","article-title":"Dissociable hindbrain GLP1R circuits for satiety and aversion","volume":"632","author":"Huang","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2026.06.015_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111698","article-title":"Acute changes in systemic glycemia gate access and action of GLP-1R agonist on brain structures controlling energy homeostasis","volume":"41","author":"Bakker","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.biopsych.2026.06.015_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12576-024-00904-9","article-title":"Satiety: A gut-brain-relationship","volume":"74","author":"Barakat","year":"2024","journal-title":"J Physiol Sci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.863184","article-title":"The role of GLP-1 signaling in hypoglycemia due to hyperinsulinism","volume":"13","author":"Danowitz","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.biopsych.2026.06.015_bib43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1037\/amp0000059","article-title":"Liking, wanting, and the incentive-sensitization theory of addiction","volume":"71","author":"Berridge","year":"2016","journal-title":"Am Psychol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3758\/s13415-011-0068-4","article-title":"Motivational states influence effort-based decision making in rats: The role of dopamine in the nucleus accumbens","volume":"12","author":"Mai","year":"2012","journal-title":"Cogn Affect Behav Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib45","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.appet.2011.06.009","article-title":"Males and females show differential brain activation to taste when hungry and sated in gustatory and reward areas","volume":"57","author":"Haase","year":"2011","journal-title":"Appetite"},{"key":"10.1016\/j.biopsych.2026.06.015_bib46","doi-asserted-by":"crossref","first-page":"9632","DOI":"10.1523\/JNEUROSCI.23-29-09632.2003","article-title":"Dissociable contributions of the human amygdala and orbitofrontal cortex to incentive motivation and goal selection","volume":"23","author":"Arana","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib47","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.221404","article-title":"The psychological basis of reductions in food desire during satiety","volume":"10","author":"Stevenson","year":"2023","journal-title":"R Soc Open Sci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fendo.2017.00104","article-title":"Hunger and satiety gauge reward sensitivity","volume":"8","author":"Cassidy","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.biopsych.2026.06.015_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/379069a0","article-title":"A role for glucagon-like peptide-1 in the central regulation of feeding","volume":"379","author":"Turton","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2026.06.015_bib50","first-page":"R848","article-title":"Central administration of GLP-1-(7\u201336) amide inhibits food and water intake in rats","volume":"271","author":"Tang-Christensen","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101351","article-title":"GLP-1 physiology informs the pharmacotherapy of obesity","volume":"57","author":"Drucker","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib52","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","article-title":"The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: A new role for mesolimbic GLP-1 receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib53","doi-asserted-by":"crossref","first-page":"R885","DOI":"10.1152\/ajpregu.00520.2015","article-title":"GLP-1 and weight loss: Unraveling the diverse neural circuitry","volume":"310","author":"Kanoski","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib54","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/npp.2017.225","article-title":"Glucagon-like peptide-1 receptor signaling in the lateral dorsal tegmental nucleus regulates energy balance","volume":"43","author":"Reiner","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat Rev Neurosci"},{"issue":"suppl 1","key":"10.1016\/j.biopsych.2026.06.015_bib56","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1055\/s-0028-1124107","article-title":"Dopamine, reinforcement learning, and addiction","volume":"42","author":"Dayan","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopsych.2026.06.015_bib57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-024-08412-x","article-title":"Opponent control of reinforcement by striatal dopamine and serotonin","volume":"639","author":"Cardozo Pinto","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2026.06.015_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresbull.2022.01.019","article-title":"Complexities and paradoxes in understanding the role of dopamine in incentive motivation and instrumental action: Exertion of effort vs. anhedonia","volume":"182","author":"Salamone","year":"2022","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.biopsych.2026.06.015_bib59","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.neuron.2010.11.022","article-title":"Dopamine in motivational control: rewarding, aversive, and alerting","volume":"68","author":"Bromberg-Martin","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2026.06.015_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113376","article-title":"Incentive motivation: \u2018wanting\u2019 roles of central amygdala circuitry","volume":"411","author":"Warlow","year":"2021","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2026.06.015_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/chemse\/bjac009","article-title":"Target-specific projections of amygdala somatostatin-expressing neurons to the hypothalamus and brainstem","volume":"47","author":"Bartonjo","year":"2022","journal-title":"Chem Senses"},{"key":"10.1016\/j.biopsych.2026.06.015_bib62","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cobeha.2016.02.005","article-title":"GLP-1 influences food and drug reward","volume":"9","author":"Hayes","year":"2016","journal-title":"Curr Opin Behav Sci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119034","article-title":"Activation of the GLP-1 receptors in the nucleus of the solitary tract reduces food reward behavior and targets the mesolimbic system","volume":"10","author":"Richard","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2026.06.015_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn5345","article-title":"Glucose-sensing glucagon-like peptide-1 receptor neurons in the dorsomedial hypothalamus regulate glucose metabolism","volume":"8","author":"Huang","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.biopsych.2026.06.015_bib65","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.neuron.2025.03.010","article-title":"The neurobiology of overeating","volume":"113","author":"Stuber","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2026.06.015_bib66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0031-9384(81)90310-3","article-title":"Sensory specific satiety in man","volume":"27","author":"Rolls","year":"1981","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2026.06.015_bib67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1753-4887.1986.tb07593.x","article-title":"Sensory-specific satiety","volume":"44","author":"Rolls","year":"1986","journal-title":"Nutr Rev"},{"key":"10.1016\/j.biopsych.2026.06.015_bib68","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/mp.2017.91","article-title":"A hippocampus to prefrontal cortex neural pathway inhibits food motivation through glucagon-like peptide-1 signaling","volume":"23","author":"Hsu","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.015_bib69","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/npp.2014.175","article-title":"Hippocampal GLP-1 receptors influence food intake, meal size, and effort-based responding for food through volume transmission","volume":"40","author":"Hsu","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8071","article-title":"GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats","volume":"12","author":"Fortin","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biopsych.2026.06.015_bib71","article-title":"A single dorsal vagal complex circuit mediates the aversive and anorectic responses to GLP1R agonists","author":"Yacawych","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopsych.2026.06.015_bib72","doi-asserted-by":"crossref","first-page":"E661","DOI":"10.1152\/ajpendo.00528.2024","article-title":"GLP-1 receptor agonist exendin-4 suppresses food intake by inhibiting hindbrain orexigenic NPY neurons","volume":"328","author":"Shen","year":"2025","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib73","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.cub.2024.02.074","article-title":"A brainstem to hypothalamic arcuate nucleus GABAergic circuit drives feeding","volume":"34","author":"Martinez de Morentin","year":"2024","journal-title":"Curr Biol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib74","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1523\/JNEUROSCI.3579-15.2016","article-title":"Astrocytes regulate GLP-1 receptor-mediated effects on energy balance","volume":"36","author":"Reiner","year":"2016","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib75","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biopsych.2026.06.015_bib76","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00429-014-0714-z","article-title":"Distribution of glucagon-like peptide 1-immunopositive neurons in human caudal medulla","volume":"220","author":"Zheng","year":"2015","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.biopsych.2026.06.015_bib77","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2010.03.059","article-title":"Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure","volume":"1350","author":"Rinaman","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2026.06.015_bib78","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib79","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/npp.2014.74","article-title":"Glucagon-like Peptide-1 receptor signaling in the lateral parabrachial nucleus contributes to the control of food intake and motivation to feed","volume":"39","author":"Alhadeff","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib80","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1210\/en.2014-1248","article-title":"GLP-1 receptor stimulation of the lateral parabrachial nucleus reduces food intake: Neuroanatomical, electrophysiological, and behavioral evidence","volume":"155","author":"Richard","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib81","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1038\/npp.2015.50","article-title":"Parabrachial nucleus contributions to glucagon-like peptide-1 receptor agonist-induced hypophagia","volume":"40","author":"Swick","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib82","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuroscience.2016.12.039","article-title":"Direct effects of glucose, insulin, GLP-1, and GIP on bulbospinal neurons in the rostral ventrolateral medulla in neonatal Wistar rats","volume":"344","author":"Oshima","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2026.06.015_bib83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI0215595","article-title":"Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons","volume":"110","author":"Yamamoto","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biopsych.2026.06.015_bib84","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4236\/jbbs.2021.119016","article-title":"A functional inhibitory role of habenular glucagon-like peptide-1 (GLP-1) in forebrain reward signaling","volume":"11","author":"Johnson","year":"2021","journal-title":"J Behav Brain Sci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib85","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib86","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuroscience.2012.09.071","article-title":"Preproglucagon (PPG) neurons innervate neurochemically identified autonomic neurons in the mouse brainstem","volume":"229","author":"Llewellyn-Smith","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2026.06.015_bib87","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.adj2537","article-title":"GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans","volume":"385","author":"Kim","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2026.06.015_bib88","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/mp.2017.187","article-title":"Lateral hypothalamic GLP-1 receptors are critical for the control of food reinforcement, ingestive behavior and body weight","volume":"23","author":"L\u00f3pez-Ferreras","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.015_bib89","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.2032-23.2024","article-title":"GLP-1 in the hypothalamic paraventricular nucleus promotes sympathetic activation and hypertension","volume":"44","author":"Xu","year":"2024","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib90","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.physbeh.2013.04.003","article-title":"Role of central glucagon-like peptide-1 in stress regulation","volume":"122","author":"Ghosal","year":"2013","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2026.06.015_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102076","article-title":"Modulation of stress-related behaviour by preproglucagon neurons and hypothalamic projections to the nucleus of the solitary tract","volume":"91","author":"Holt","year":"2025","journal-title":"Mol Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib92","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bph.15576","article-title":"The role of nucleus of the solitary tract glucagon-like peptide-1 and prolactin-releasing peptide neurons in stress: Anatomy, physiology and cellular interactions","volume":"179","author":"Holt","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib93","doi-asserted-by":"crossref","first-page":"E1367","DOI":"10.1152\/ajpendo.00413.2013","article-title":"The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA\/kainate receptors","volume":"305","author":"Mietlicki-Baase","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib94","doi-asserted-by":"crossref","first-page":"E1314","DOI":"10.1152\/ajpendo.00137.2013","article-title":"Nucleus accumbens GLP-1 receptors influence meal size and palatability","volume":"304","author":"Dossat","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib95","doi-asserted-by":"crossref","first-page":"14453","DOI":"10.1523\/JNEUROSCI.3262-11.2011","article-title":"Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake","volume":"31","author":"Dossat","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib96","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1523\/JNEUROSCI.0115-14.2014","article-title":"Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA\/kainate signaling","volume":"34","author":"Mietlicki-Baase","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib97","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/s41386-018-0010-3","article-title":"Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats","volume":"43","author":"Hernandez","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib98","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2026.06.015_bib99","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.drugalcdep.2017.07.033","article-title":"Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses","volume":"180","author":"Bouhlal","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2026.06.015_bib100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13722-024-00481-7","article-title":"Ecological momentary assessment and cue-elicited drug craving as primary endpoints: Study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder","volume":"19","author":"Freet","year":"2024","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.biopsych.2026.06.015_bib101","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/ADM.0000000000001147","article-title":"Feasibility of exenatide, a GLP-1R agonist, for treating cocaine use disorder: A case series study","volume":"17","author":"Yammine","year":"2023","journal-title":"J Addict Med"},{"key":"10.1016\/j.biopsych.2026.06.015_bib102","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40618-014-0091-8","article-title":"Effects of cocaine on the hypothalamic-pituitary-adrenal axis","volume":"37","author":"Manetti","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.biopsych.2026.06.015_bib103","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0306-4530(01)00034-8","article-title":"The HPA axis and cocaine reinforcement","volume":"27","author":"Goeders","year":"2002","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib104","doi-asserted-by":"crossref","DOI":"10.1080\/23312025.2016.1229086","article-title":"The physiological role of the brain GLP-1 system in stress","volume":"2","author":"Holt","year":"2016","journal-title":"Cogent Biol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib105","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.3390\/nu12113304","article-title":"Glucagon-like Peptide-1 (GLP-1) in the integration of neural and endocrine responses to stress","volume":"12","author":"Diz-Chaves","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biopsych.2026.06.015_bib106","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1073\/pnas.0808716106","article-title":"Glucocorticoid regulation of preproglucagon transcription and RNA stability during stress","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2026.06.015_bib107","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.physbeh.2019.03.026","article-title":"Central GLP-1 receptors: Novel molecular targets for cocaine use disorder","volume":"206","author":"Hernandez","year":"2019","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2026.06.015_bib108","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00213-023-06376-w","article-title":"Liraglutide attenuates nicotine self-administration as well as nicotine seeking and hyperphagia during withdrawal in male and female rats","volume":"240","author":"Herman","year":"2023","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.biopsych.2026.06.015_bib109","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nn.4540","article-title":"GLP-1 acts on habenular avoidance circuits to control nicotine intake","volume":"20","author":"Tuesta","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112466","article-title":"GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity","volume":"42","author":"Falk","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.biopsych.2026.06.015_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077284","article-title":"The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice","volume":"8","author":"Egecioglu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2026.06.015_bib112","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/ntr\/ntab066","article-title":"Exenatide adjunct to nicotine patch facilitates smoking cessation and may reduce post-cessation weight gain: A pilot randomized controlled trial","volume":"23","author":"Yammine","year":"2021","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.biopsych.2026.06.015_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101865","article-title":"Effect of dulaglutide in promoting abstinence during smoking cessation: A single-centre, randomized, double-blind, placebo-controlled, parallel group trial","volume":"57","author":"Lengsfeld","year":"2023","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.biopsych.2026.06.015_bib114","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.physbeh.2015.06.013","article-title":"The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice","volume":"149","author":"S\u00f8rensen","year":"2015","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2026.06.015_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069010","article-title":"The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice","volume":"8","author":"Egecioglu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2026.06.015_bib116","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/mp.2012.141","article-title":"GLP-1 analog attenuates cocaine reward","volume":"18","author":"Graham","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.015_bib117","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/npp.2015.362","article-title":"Glucagon-like peptide-1 receptor activation in the ventral tegmental area decreases the reinforcing efficacy of cocaine","volume":"41","author":"Schmidt","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104642","article-title":"Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats","volume":"93","author":"Aran\u00e4s","year":"2023","journal-title":"EBiomedicine"},{"key":"10.1016\/j.biopsych.2026.06.015_bib119","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170671","article-title":"The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission","volume":"8","author":"Chuong","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopsych.2026.06.015_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.599646","article-title":"Long-acting glucagon-like peptide-1 receptor agonists suppress voluntary alcohol intake in Male Wistar Rats","volume":"14","author":"Marty","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.015_bib121","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41398-020-00923-1","article-title":"Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats","volume":"10","author":"Vall\u00f6f","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.015_bib122","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pbb.2017.07.014","article-title":"The glucagon-like peptide 1 receptor agonist exendin-4 decreases relapse-like drinking in socially housed mice","volume":"160","author":"Thomsen","year":"2017","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2026.06.015_bib123","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1111\/acer.13199","article-title":"Effects of the GLP-1 agonist Exendin-4 on intravenous ethanol self-administration in mice","volume":"40","author":"S\u00f8rensen","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.biopsych.2026.06.015_bib124","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/adb.12295","article-title":"The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents","volume":"21","author":"Vall\u00f6f","year":"2016","journal-title":"Addict Biol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib125","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.psyneuen.2012.11.009","article-title":"The glucagon-like peptide 1 analogue exendin-4 attenuates alcohol mediated behaviors in rodents","volume":"38","author":"Egecioglu","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061965","article-title":"Gut peptide GLP-1 and its analogue, exendin-4, decrease alcohol intake and reward","volume":"8","author":"Shirazi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2026.06.015_bib127","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00213-018-5089-z","article-title":"Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys","volume":"236","author":"Thomsen","year":"2019","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.biopsych.2026.06.015_bib128","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170419","article-title":"Effects of dulaglutide on alcohol consumption during smoking cessation","volume":"8","author":"Probst","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopsych.2026.06.015_bib129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.brainresbull.2022.08.022","article-title":"Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats","volume":"189","author":"Evans","year":"2022","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.biopsych.2026.06.015_bib130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/FBP.0000000000000609","article-title":"Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats","volume":"32","author":"Douton","year":"2021","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib131","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/FBP.0000000000000805","article-title":"Effect of acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, and estrus phase on cue- and drug-induced fentanyl seeking in female rats","volume":"36","author":"Urbanik","year":"2025","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108599","article-title":"A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats","volume":"192","author":"Zhang","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib133","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41386-019-0531-4","article-title":"Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats","volume":"45","author":"Zhang","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib134","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39945","article-title":"Dopamine neurons projecting to medial shell of the nucleus accumbens drive heroin reinforcement","volume":"7","author":"Corre","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.biopsych.2026.06.015_bib135","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1464-5491.2008.02412.x","article-title":"Cocaine decreases plasma insulin concentrations in non-diabetic subjects: A randomized double-blind study","volume":"25","author":"Rott","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.biopsych.2026.06.015_bib136","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/BF02532386","article-title":"Feeding, drug abuse, and the sensitization of reward by metabolic need","volume":"21","author":"Carr","year":"1996","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biopsych.2026.06.015_bib137","doi-asserted-by":"crossref","first-page":"R1266","DOI":"10.1152\/ajpregu.00028.2011","article-title":"Food reward, hyperphagia, and obesity","volume":"300","author":"Berthoud","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib138","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s43016-022-00688-4","article-title":"Ad libitum meal energy intake is positively influenced by energy density, eating rate and hyper-palatable food across four dietary patterns","volume":"4","author":"Fazzino","year":"2023","journal-title":"Nat Food"},{"key":"10.1016\/j.biopsych.2026.06.015_bib139","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4239\/wjd.v7.i20.572","article-title":"Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity","volume":"7","author":"Anandhakrishnan","year":"2016","journal-title":"World J Diabetes"},{"key":"10.1016\/j.biopsych.2026.06.015_bib140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/dom.14843","article-title":"Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents","volume":"25","author":"Geisler","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib141","doi-asserted-by":"crossref","first-page":"R465","DOI":"10.1152\/ajpregu.00179.2014","article-title":"Hindbrain nucleus tractus solitarius glucagon-like peptide-1 receptor signaling reduces appetitive and motivational aspects of feeding","volume":"307","author":"Alhadeff","year":"2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.biopsych.2026.06.015_bib142","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41386-024-01981-5","article-title":"GLP-1 receptor agonist exenatide uncouples food intake from hedonic and anticipatory regulation in non-human primates: Insights from an operant meal schedule paradigm","volume":"50","author":"Knakker","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib143","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1210\/clinem\/dgz140","article-title":"GLP-1 analog modulates appetite, taste preference, gut hormones, and regional body fat stores in adults with obesity","volume":"105","author":"Kadouh","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib144","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/aps.2011.168","article-title":"Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats","volume":"33","author":"Hansen","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.biopsych.2026.06.015_bib145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/db06-0565","article-title":"Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not","volume":"56","author":"Raun","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.biopsych.2026.06.015_bib146","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1210\/en.2014-1052","article-title":"Long term exendin-4 treatment reduces food intake and body weight and alters expression of brain homeostatic and reward markers","volume":"155","author":"Yang","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopsych.2026.06.015_bib147","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.peptides.2013.07.015","article-title":"Alteration of sweet taste in high-fat diet induced obese rats after 4 weeks treatment with exenatide","volume":"47","author":"Zhang","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.biopsych.2026.06.015_bib148","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dom.14255","article-title":"Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes","volume":"23","author":"Gibbons","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib149","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.14280","article-title":"The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity","volume":"23","author":"Friedrichsen","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib150","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.2337\/db14-0849","article-title":"GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans","volume":"63","author":"van Bloemendaal","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.biopsych.2026.06.015_bib151","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/dom.12506","article-title":"Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans","volume":"17","author":"van Bloemendaal","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.biopsych.2026.06.015_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.638504","article-title":"Obesity and dietary added sugar interact to affect postprandial GLP-1 and its relationship to striatal responses to food cues and feeding behavior","volume":"12","author":"Jones","year":"2021","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326013545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326013545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:29:18Z","timestamp":1789846158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322326013545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":152,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0006322326013545"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.06.015","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From Satiety to Substance Use: Neural Mechanisms of Glucagon-Like Peptide-1 Signaling in Appetite and Reward","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}